Bevacizumab, pertuzumab, and sandostatin for patients (pts) with advanced neuroendocrine cancers (NET) Meeting Abstract

cited authors

  • Firdaus, Irfan, Shih, Kent C., Zakari, Ahmed, Lang, Evan Z., McCleod, Michael, Alguire, Kathryn B., Peacock, Nancy Walker, Flora, Douglas B., Ruehlman, Peter, Earwood, Chris, Bendell, Johanna C.

authors

Publication Date

  • May 20, 2012

webpage

published in

category

volume

  • 30

issue

  • 15

WoS Citations

  • 3

WoS References

  • 0